SynthesisFrontiers in neurology2026
Evidence, strategies, and pathways for thrombectomy in medium vessel occlusion stroke: a systematic review.
Synthesis in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Medium vessel occlusions (MeVOs) account for 25-40% of acute ischemic strokes and present a significant therapeutic frontier. Despite high technical success rates of endovascular thrombectomy (EVT), recent randomized trial results have been nuanced, creating a paradox and underscoring the need for a precision-based approach. Methods: We conducted a systematic review following PRISMA guidelines. After screening, 42 original studies were included (4 RCTs and 38 cohort studies). Evidence was synthesized and appraised using a three-tiered hierarchy. The GRADE framework was applied. Overall certainty of evidence ranged from moderate to very low. Results: Observational studies, which often enrolled populations with higher baseline NIHSS scores and stricter imaging selection criteria, generally reported favorable functional independence rates (mRS 0-2 in 60-80% of EVT-treated patients). However, these rates may partly reflect selection bias rather than a purely treatment-related effect. Successful recanalization is frequently achieved (>85%), but safety concerns like symptomatic hemorrhage and vessel perforation require careful management. Success hinges on a precision strategy integrating advanced imaging (e.g., CT perfusion for "Target Mismatch") with a tailored technical arsenal. This includes dedicated low-profile stent retrievers and aspiration catheters, selected based on occlusion site, thrombus burden, and anatomy. A "Eight Keys" framework interprets neutral trial results, highlighting patient selection heterogeneity. Future progress depends on refined imaging criteria, dedicated device development, and validated selection tools. Conclusion: Current randomized evidence does not demonstrate an overall functional benefit of endovascular thrombectomy (EVT) for unselected MeVO stroke, while procedure-related hemorrhagic risk appears higher than with best medical therapy. EVT may be reasonable in carefully selected patients with disabling deficits, salvageable tissue, and favorable anatomy, when performed by experienced teams using distal-appropriate techniques. Future work should prioritize validated selection tools, standardized imaging definitions, distal-specific devices, and trial designs enriched for patients most likely to benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.